Left ventricular hypertrophy in renal failure

作者: Kerstin Amann , Ivan Rychlík , Gabriel Miltenberger-Milteny , Eberhard Ritz

DOI: 10.1046/J.1523-1755.1998.06818.X

关键词: Angiotensin-converting enzymeBlood pressureConcentric hypertrophyPreloadAfterloadInternal medicineHypervolemiaLeft ventricular hypertrophyRenal replacement therapyCardiologyMedicine

摘要: Left ventricular hypertrophy in renal failure. In patients with terminal failure, left (LVH) is extremely common. It found approximately 60 to 80% of starting replacement therapy. The main causes LVH are increased preload from hypervolemia and afterload peripheral resistance, giving rise a mixture excentric concentric hypertrophy, but other factors (high cardiac output anemia arteriovenous (A-V) fistula, altered compliance central arteries, activation local systems such as renin endothelin) also play role. clinical importance derives the fact that predictor death dialyzed independent blood pressure. accompanied by microvascular disease marked interstitial fibrosis (more than seen non-renal similar degrees hypertension). Recent findings suggest LV remodeling starts early even normotensive glomerulonephritis when GFR still normal. strategies reduce include reduction hypervolemia, (near) normalization hemoglobin lowering pressure, particularly administration angiotensin converting enzyme inhibitors.

参考文章(39)
Sniderman Ad, Racine N, Barre P, Silberberg J, Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Canadian Journal of Cardiology. ,vol. 6, pp. 1- 4 ,(1990)
Gérard M. London, Alain P. Guerin, Sylvain J. Marchais, Bruno Pannier, Michel E. Safar, Martin Day, Fabien Metivier, Cardiac and arterial interactions in end-stage renal disease Kidney International. ,vol. 50, pp. 600- 608 ,(1996) , 10.1038/KI.1996.355
Jürgen Hüting, Wilfried Kramer, Georg Schütterle, Volker Wizemann, Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron. ,vol. 49, pp. 284- 290 ,(1988) , 10.1159/000185077
G. Zuanetti, A. Maggioni, W. Keane, E. Ritz, Nephrologists neglect administration of betablockers to dialysed diabetic patients. Nephrology Dialysis Transplantation. ,vol. 12, pp. 2497- 2500 ,(1997) , 10.1093/NDT/12.12.2497
Gérard M. London, Brigitte Zins, Bruno Pannier, Catherine Naret, Jean-Michel Berthelot, Christian Jacquot, Michel Safar, Tilman B. Drueke, Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney International. ,vol. 36, pp. 878- 882 ,(1989) , 10.1038/KI.1989.274
Gerard M. London, Sylvain J. Marchais, Michel E. Safar, Albert F. Genest, Alain P. Guerin, Fabien Metivier, Khalil Chedid, Alena M. London, Aortic and large artery compliance in end-stage renal failure Kidney International. ,vol. 37, pp. 137- 142 ,(1990) , 10.1038/KI.1990.19
Daniel Levy, Keaven M. Anderson, Daniel D. Savage, Susan A. Balkus, William B. Kannel, William P. Castelli, Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham Heart Study American Journal of Cardiology. ,vol. 60, pp. 560- 565 ,(1987) , 10.1016/0002-9149(87)90305-5
Michael J Koren, Richard B Devereux, Paul N Casale, Daniel D Savage, John H Laragh, Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension Annals of Internal Medicine. ,vol. 114, pp. 345- 352 ,(1991) , 10.7326/0003-4819-114-5-345
Graham w. Lipkin, Beatriz Tucker, Martin Giles, Anthony E.G. Raine, Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. Journal of Hypertension. ,vol. 11, pp. 439- 442 ,(1993) , 10.1097/00004872-199304000-00015
Vito M. Campese, Ella Kogosov, Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure Hypertension. ,vol. 25, pp. 878- 882 ,(1995) , 10.1161/01.HYP.25.4.878